The results of that study showed an increase in the toxicity of this ligand when combined with the inhibitor, an interesting example of the use of ATR as a target to induce cell death in MM cells and to abrogate resistance to MEDI2228. This evidence concerns the gene ATR and Miyoshi myopathy.